| [1] |
Marsh EE, Wegienka G, Williams DR. Uterine fibroids[J]. JAMA,2024,331(17):1492-1493.
|
| [2] |
冯烨,杨慧霞. 妊娠合并子宫肌瘤的诊疗新进展[J]. 中华妇产科杂志,2025,60(5):399-402.
|
| [3] |
Parazzini F, Tozzi L, Bianchi S. Pregnancy outcome and uterine fibroids[J]. Best Pract Res Clin Obstet Gynaecol,2016,34:74-84.
|
| [4] |
子宫肌瘤的诊治中国专家共识专家组. 子宫肌瘤的诊治中国专家共识[J]. 中华妇产科杂志,2017,52(12):793-800.
|
| [5] |
中华医学会围产医学分会,中华医学会妇产科学分会产科学组. 高龄妇女孕期管理专家共识[J]. 中华围产医学杂志,2024,27(6):441-449.
|
| [6] |
胡丽娜,李金科.子宫肌瘤恶变的诊断与治疗[J]. 实用妇产科杂志,2007,23(12):718-720.
|
| [7] |
Schwartz PE, Kelly MG. Malignant transformation of myomas: myth or reality?[J]. Obstet Gynecol Clin North Am,2006,33(1):183-198, xii.
|
| [8] |
Rotmensch J, Bosnyak S, Montag A. Malignant transition of uterine leiomyomata[J]. Int J Gynaecol Obstet,1993,42(1):47-49.
|
| [9] |
Mittal K, Joutovsky A. Areas with benign morphologic and immunohistochemical features are associated with some uterine leiomyosarcomas[J]. Gynecol Oncol,2007,104(2):362-365.
|
| [10] |
Mittal KR, Chen F, Wei JJ, et al. Molecular and immunohistochemical evidence for the origin of uterine leiomyosarcomas from associated leiomyoma and symplastic leiomyoma-like areas[J]. Mod Pathol,2009,22(10):1303-1311.
|
| [11] |
Leibsohn S, d′Ablaing G, Mishell DR, et al. Leiomyosarcoma in a series of hysterectomies performed for presumed uterine leiomyomas[J]. Am J Obstet Gynecol,1990,162(4):968-974; discussion 974-976.
|
| [12] |
Eastwood-Wilshere N, Turner J, Oliveira N, et al. Metastatic uterine leiomyosarcoma at 26 weeks gestation[J]. BMJ Case Rep,2019,12(8):e230028.
|
| [13] |
Hand LC, Gimovsky AC, Chan JSY, et al. Incidental leiomyosarcoma found at the time of cesarean hysterectomy for morbidly adherent placenta[J]. Gynecol Oncol Rep,2017,20:127-130.
|
| [14] |
Bodner-Adler B, Lozano P, Bodner K, et al. Primary uterine leiomyosarcoma and primary atypical meningioma diagnosed during pregnancy[J]. Anticancer Res,2008,28(5B):3083-3085.
|
| [15] |
Gojnic M, Likic I, Pervulov M, et al. The significance of Doppler flow in early detection of uterine sarcoma in older primigravida pregnancies[J]. Eur J Gynaecol Oncol,2005,26(3):291-293.
|
| [16] |
Bekkers RL, Massuger LF, Berg PP, et al. Uterine malignant leiomyoblastoma (epithelioid leiomyosarcoma) during pregnancy[J]. Gynecol Oncol,1999,72(3):433-436.
|
| [17] |
Lau TK, Wong WS. Uterine leiomyosarcoma associated with pregnancy: report of two cases[J]. Gynecol Oncol,1994,53(2):245-247.
|
| [18] |
King TM, Atienza MF, Burkman RT. The incidence of abdominal surgical procedures in a population undergoing abortion[J]. Am J Obstet Gynecol,1980,137(5):530-533.
|
| [19] |
Younis JS, Okon E, Anteby SO. Uterine leiomyosarcoma in pregnancy[J]. Arch Gynecol Obstet,1990,247(3):155-160.
|
| [20] |
Kyodo Y, Inatomi K, Abe T. Sarcoma associated with pregnancy[J]. Am J Obstet Gynecol,1989,161(1):94-96.
|
| [21] |
Wolfe SA, Seckinger D. Sarcoma of the uterus associated with pregnancy[J]. Am J Obstet Gynecol,1969,104(8):1215-1216.
|
| [22] |
高俊臣. 子宫平滑肌肉瘤合并妊娠1例报道[J].肿瘤,1983(1):30.
|
| [23] |
古雅丽,杨广英. 子宫平滑肌肉瘤合并妊娠1例[J]. 河南肿瘤学杂志,1993,(2):96.
|
| [24] |
杨莹超,李小平,王世军,等.妊娠合并Ⅳ期子宫肉瘤一例[J]. 中华妇产科杂志,2014,49(9):705.
|
| [25] |
周晶文,杨艳秋.单角子宫足月妊娠合并子宫肌瘤肉瘤变性1例报告[J]. 吉林医学,2006,27(1):44, 46.
|
| [26] |
Skorstad M, Kent A, Lieng M. Preoperative evaluation in women with uterine leiomyosarcoma. A nationwide cohort study[J]. Acta Obstet Gynecol Scand,2016,95(11):1228-1234.
|
| [27] |
D′Angelo E, Prat J. Uterine sarcomas: a review[J]. Gynecol Oncol,2010,116(1):131-139.
|
| [28] |
Luigi GD, D′Alfonso A, Patacchiola F, et al. Leiomyosarcoma: a rare malignant transformation of a uterine leiomyoma[J]. Eur J Gynaecol Oncol,2015,36(1):84-87.
|
| [29] |
郝敏,赵卫红,王文静. 子宫肌瘤肉瘤变特点及其相关问题[J]. 中国实用妇科与产科杂志,2012,28(12):892-895.
|
| [30] |
Matsuo K, Eno ML, Im DD, et al. Pregnancy and genital sarcoma: a systematic review of the literature[J]. Am J Perinatol,2009,26(7):507-518.
|
| [31] |
孔宪超,宋铁芳. 影像学检查在妊娠合并妇科肿瘤诊断中的应用[J]. 中国实用妇科与产科杂志,2018,34(10):1098-1102.
|
| [32] |
Sun S, Bonaffini PA, Nougaret S, et al. How to differentiate uterine leiomyosarcoma from leiomyoma with imaging[J]. Diagn Interv Imaging,2019,100(10):619-634.
|
| [33] |
Exacoustos C, Romanini ME, Amadio A, et al. Can gray-scale and color Doppler sonography differentiate between uterine leiomyosarcoma and leiomyoma?[J]. J Clin Ultrasound,2007,35(8):449-457.
|
| [34] |
Ray JG, Vermeulen MJ, Bharatha A, et al. Association between MRI exposure during pregnancy and fetal and childhood outcomes[J]. JAMA,2016,316(9):952-961.
|
| [35] |
Lin Y, Wu R, Huang Y, et al. Uterine fibroid-like tumors: spectrum of MR imaging findings and their differential diagnosis[J]. Abdom Radiol (NY),2022,47(6):2197-2208.
|
| [36] |
Ando T, Kato H, Furui T, et al. Uterine smooth muscle tumours with hyperintense area on T1 weighted images: differentiation between leiomyosarcomas and leiomyomas[J]. Br J Radiol,2018,91(1084):20170767.
|
| [37] |
Virarkar M, Diab R, Palmquist S, et al. Diagnostic performance of MRI to differentiate uterine leiomyosarcoma from benign leiomyoma: a meta-analysis[J]. J Belg Soc Radiol,2020,104(1):69.
|
| [38] |
DeMulder D, Ascher SM. Uterine Leiomyosarcoma: can MRI differentiate leiomyosarcoma from benign leiomyoma before treatment?[J]. AJR Am J Roentgenol,2018,211(6):1405-1415.
|
| [39] |
Gaetke-Udager K, McLean K, Sciallis AP, et al. Diagnostic accuracy of ultrasound, contrast-enhanced CT, and conventional MRI for differentiating leiomyoma from leiomyosarcoma[J]. Acad Radiol,2016,23(10):1290-1297.
|
| [40] |
Sato K, Yuasa N, Fujita M, et al. Clinical application of diffusion-weighted imaging for preoperative differentiation between uterine leiomyoma and leiomyosarcoma[J]. Am J Obstet Gynecol,2014,210(4):368.e1-368.e8.
|
| [41] |
杨子馨,郑莹. 子宫肌瘤恶变的无创性诊断方法[J]. 实用妇产科杂志,2024,40(2):96-99.
|
| [42] |
Woo S, Beier SR, Tong A, et al. Utility of ADC values for differentiating uterine sarcomas from leiomyomas: systematic review and meta-analysis[J]. AJR Am J Roentgenol,2024,223(3):e2431280.
|
| [43] |
Maryam F, Chameli S, Mustafa G. Challenges in diagnosing uterine leiomyosarcoma in pregnancy: a case report and lessons learned[J]. Cureus,2025,17(10):e94530.
|
| [44] |
Taliento C, De Bruyn C, Ceusters J, et al. Circulating biomarkers for the preoperative diagnosis of uterine sarcoma: a systematic review and meta-analysis[J]. Maturitas,2025,199:108634.
|
| [45] |
Makkonen M, Penttilä IM, Castrén O. Serum lactic acid dehydrogenase and isoenzymes during pregnancy and labor[J]. Acta Obstet Gynecol Scand,1980,59(2):97-102.
|
| [46] |
中国抗癌协会妇科肿瘤专业委员会.子宫肉瘤诊断与治疗指南(2021年版)[J].中国癌症杂志,2021,31(6):513-519.
|
| [47] |
杨如玉,韦雅婧,梁炎春. 子宫平滑肌肉瘤的治疗策略和方法[J].实用妇产科杂志,2024,40(2):99-102.
|
| [48] |
National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology-uterine neoplasms[EB/OL]. (2025-09-27)[2025-10-18].
URL
|
| [49] |
中华医学会妇科肿瘤学分会. 中国妇科肿瘤临床实践指南(2024版)[M]. 北京:科学技术文献出版社,2024:19-44.
|
| [50] |
Hensley ML, Wathen JK, Maki RG, et al. Adjuvant therapy for high-grade, uterus-limited leiomyosarcoma: results of a phase 2 trial (SARC 005)[J]. Cancer,2013,119(8):1555-1561.
|
| [51] |
Ricci S, Giuntoli RL, Eisenhauer E, et al. Does adjuvant chemotherapy improve survival for women with early-stage uterine leiomyosarcoma?[J]. Gynecol Oncol,2013,131(3):629-633.
|
| [52] |
Roque DR, Taylor KN, Palisoul M, et al. Gemcitabine and docetaxel compared with observation, radiation, or other chemotherapy regimens as adjuvant treatment for stage I-to-IV uterine leiomyosarcoma[J]. Int J Gynecol Cancer,2016,26(3):505-511.
|
| [53] |
Desar IME, Ottevanger PB, Benson C, et al. Systemic treatment in adult uterine sarcomas[J]. Crit Rev Oncol Hematol,2018,122:10-20.
|
| [54] |
黎璞,生秀杰. 妊娠合并子宫颈癌的管理[J/OL]. 中华产科急救电子杂志,2024,13(4):202-208.
|
| [55] |
Yang Q, Madueke-Laveaux OS, Cun H, et al. Comprehensive review of uterine leiomyosarcoma: pathogenesis, diagnosis, prognosis, and targeted therapy[J]. Cells,2024,13(13):1106.
|
| [56] |
Roberts ME, Aynardi JT, Chu CS. Uterine leiomyosarcoma: a review of the literature and update on management options[J]. Gynecol Oncol,2018,151(3):562-572.
|